115 related articles for article (PubMed ID: 2991215)
1. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Spector T; Jones TE
J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
[TBL] [Abstract][Full Text] [Related]
2. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Sato A; Bacon PE; Cory JG
Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2.
Cohen EA; Charron J; Perret J; Langelier Y
J Gen Virol; 1985 Apr; 66 ( Pt 4)():733-45. PubMed ID: 2984316
[TBL] [Abstract][Full Text] [Related]
4. Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase.
Williams MT; Simonet L; Cory AH; Cory JG
Cancer Res; 1988 Nov; 48(22):6375-8. PubMed ID: 3052801
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
Sato A; Cory JG
Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.
Averett DR; Lubbers C; Elion GB; Spector T
J Biol Chem; 1983 Aug; 258(16):9831-8. PubMed ID: 6309786
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
Moore EC; Hurlbert RB
Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
[No Abstract] [Full Text] [Related]
8. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1.
Averett DR; Furman PA; Spector T
J Virol; 1984 Dec; 52(3):981-3. PubMed ID: 6092726
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
Cory JG; Fleischer AE
Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
Lewis WH; Wright JA
J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
Cory JG; Mansell MM; Whitford TW
Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.
Spector T
Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588
[No Abstract] [Full Text] [Related]
14. Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex.
Porter DJ; Harrington JA; Spector T
Biochem Pharmacol; 1990 Feb; 39(4):639-46. PubMed ID: 2154988
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
16. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
Matsumoto M; Tihan T; Cory JG
Cancer Chemother Pharmacol; 1990; 26(5):323-9. PubMed ID: 2208572
[TBL] [Abstract][Full Text] [Related]
17. Herpes and human ribonucleotide reductases. Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87).
Spector T; Harrington JA; Porter DJ
Biochem Pharmacol; 1991 Jun; 42(1):91-6. PubMed ID: 1648925
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
Cory JG; Sato A; Lasater L
Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
[No Abstract] [Full Text] [Related]
19. Relationships between sensitivity to hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIO) and ribonucleotide reductase RNR2 mRNA levels in strains of Saccharomyces cerevisiae.
Rittberg DA; Wright JA
Biochem Cell Biol; 1989 Jul; 67(7):352-7. PubMed ID: 2675933
[TBL] [Abstract][Full Text] [Related]
20. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
